Hyderabad-based Aurobindo Pharma has informed that it has secured approval from US Food and Drug Administration (USFDA) for marketing Cyclobenzaprine hydrochloride tablets.

Under the approval, the company will market and distribute the drug in 10 mg and 5 mg strengths. The drug is a muscle relaxant, which is prescribed to relieve muscle spasms resulting from injuries such as sprains, strains, or pulls.

Aksh Optifibre, an Indian provider of optical fibre solutions, has entered into 3-year agreement with Sony Pictures Entertainment to bring Hollywood content for iControl, to provide the best possible entertainment to the viewers.

Icontrol is a television connection allowing viewers to control television programmes as per their convenience with more than 130 channels, value added services like video on demand, time-shifting, live television voting etc.

Chennai-based Orchid Chemicals and Pharmaceuticals has entered into an arrangement with US drug maker Merck & Co. Inc. for discovery and development of novel anti-infective drugs.

Under the terms of deal, Orchid will receive an undisclosed upfront payment and will be eligible to get payment totaling more than $100 million in different milestones.

Apart from this, the Indian drug maker will also receive royalties on global sale of the drugs.

Ba

Chennai: Country’s leading car manufacturer, Maruti Suzuki India (MSIL), will launch its much-awaited ‘A-Star’ car in mid-November. A-Star would be rolled out from the company’s plant at Manesar.

Ratnagiri Gas and Power Pvt Ltd (RGPPL) has revealed its plans to double its power generation to over 1,200 megs watt by first week of October and will likely to commission the LNG terminal soon.

At present, RGPPL produces about 620 mega watt of power.

The company will set up a steam turbine power block-III and the power block would be generating about another 600-620 mega watt of power.  

According to the sources, the proposed power block is expected to ease the shortage of power situation in the state of Maharashtra.